{"name":"Medpace Holdings, Inc.","slug":"medpace","ticker":"MEDP","exchange":"NASDAQ","domain":"medpace.com","description":"Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.","hq":"Cincinnati, OH","founded":2003,"employees":"6300","ceo":"August Troendle","sector":"CRO / Pharma Services","stockPrice":422.18,"stockChange":-1.58,"stockChangePercent":-0.37,"marketCap":"$12.1B","metrics":{"revenue":2678267904,"revenueGrowth":26.5,"grossMargin":71.9,"rdSpend":0,"netIncome":451123000,"cash":497049000,"dividendYield":0,"peRatio":26.6,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Lynparza patent cliff ($1.1B at risk)","drug":"Lynparza","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Medpace Holdings, Inc. reported its fourth quarter and full year 2023 financial results, with revenue of $1.1 billion and net income of $143.8 million.","drugName":"","sentiment":"positive"},{"date":"2023-11-15","type":"deal","headline":"Medpace Holdings, Inc. Acquires Clinical Research Organization, Clinipace","summary":"Medpace Holdings, Inc. acquired Clinipace, a clinical research organization, to expand its services and capabilities.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQSWVOc08xNUJQc2F5c2NBeVRJQlZ0cDZwY3ZfZkVoVWM1d2JWSTl0X0RyaG9VOVdmQXcxa1BvOG40aDQzeVVDWlNLZktwN2JXTndmRlRaZ01NZjNlbTJkeURxRE1RZlFrUG9RZnhHV3BQRUVTbGNaNm5Vdm9hSm81OFQ2S3U4U0lZMDdFa1paQlNxS25VaklfdTZ4NGRuTXhYZkUxRmIxQkl5cG5mTnNBSmppX3JiYmF2aE1IYjVDNkhpSTR3WkJRX1Noc29ZdnJ3clByd0wzRmczUU9t?oc=5","date":"2026-04-07","type":"pipeline","source":"Business Wire","summary":"Investor Notice: Robbins LLP Informs Investors of the Medpace Holdings Inc. Class Action - Business Wire","headline":"Investor Notice: Robbins LLP Informs Investors of the Medpace Holdings Inc. Class Action","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNWGxfN3VFcVBlNVRTYXZDQjlVQXlQdk42NFFpT0k2WDQ5NDUzemhsSUdQV0t3VmNKZmdnc1VYTW1xeDR5eEJaWDNrZVZpVTJ1VXBGeC1tSUVRdmN0REFQSDZRU0pJSHVjVXdFLUI4VEMyRFROeW9hOXRiM290ZU0zSVctSnpCc296eEkwU25LR3VqRmJxSTE4WVRCVlp5emhQYUpXVmR0eDJZSGRnQlktMUFXZ2xqZw?oc=5","date":"2026-04-07","type":"pipeline","source":"National Today","summary":"Rosen Law Firm Urges Medpace Stockholders to Contact Firm - National Today","headline":"Rosen Law Firm Urges Medpace Stockholders to Contact Firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxOYU51Uk9MNjBVcUZ0Y2U4Tkh2OEQzUW5HbF9tYjVBcElxNmN5SUE4R3N4Q2h0Y2p3TkkxVFVUUl9wYkZuT1dKYWFzb0FUbHdvR3dvb2trQzNua2JrUUdfdU5qY2lBUnRLc3JyNUQ5OTBnZnVkUnU5MUVfZy1uanB3TE9iVzQ0Y2l1cXdId1l5UVNkamNnbHhvM1VXckRNdms2ODdOTU8zUWpwSVBqczYxYWtMNTZkUUpUN0xDWGxiRklNd0FkM0NrZzU4MUNrTkYwWWQyTnRpZ0RtX0kwZ3dIaGZSMmhvUVF5bVJaZkVhWEJ4UXAtdGs3dGg2ZmtsN3Y2R2hNUGJnaG1JQnM?oc=5","date":"2026-04-07","type":"pipeline","source":"Business Wire","summary":"Rosen Law Firm Urges Medpace Holdings, Inc. (NASDAQ: MEDP) Stockholders to Contact the Firm for Information About Their Rights - Business Wire","headline":"Rosen Law Firm Urges Medpace Holdings, Inc. (NASDAQ: MEDP) Stockholders to Contact the Firm for Information About Their ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOaW5EVUl0eGoxSlF4VnhiRkRyNkNNeDlsM3l0akJRUWxsMWxyZTlYcTVDU2t6dGN5eUlweWhPM09iUVJnYXVkaldJaDhOTlNuQ2t4RG1MY3Q2X2hGUHgydnRySG5kanE4RndfcVdBTlhtSmc5cUEyQ21MTFU2VHpsVDhDdUhGQ2tkQ0QyVFVzNzFWTWpzelNIMmx5MTZzNXYyTW45MGJYY3ZfRnNrOWlkMVloeEM2SFhfb2ZkZw?oc=5","date":"2026-04-07","type":"pipeline","source":"National Today","summary":"Medpace Investors Eligible to Lead Securities Fraud Lawsuit - National Today","headline":"Medpace Investors Eligible to Lead Securities Fraud Lawsuit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9lUklvSEJkOUR1YlRXbVVxdVM0OUpJNlgyNlV2NEEzWUxub2RNY096c2lMNURycEZSVm5oenkxUnpUbEZiVzBMeUJPOWxqcDBvRXhPOEJvZFFYazJfNlZv?oc=5","date":"2026-04-02","type":"pipeline","source":"ChartMill","summary":"MEDP Stock Price, Quote & Chart | MEDPACE HOLDINGS INC (NASDAQ:MEDP) - ChartMill","headline":"MEDP Stock Price, Quote & Chart | MEDPACE HOLDINGS INC (NASDAQ:MEDP)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-13","type":"pipeline","source":"simplywall.st","summary":"Medpace Holdings, Inc. (NASDAQ:MEDP) Just Reported, And Analysts Assigned A US$491 Price Target - simplywall.st","headline":"Medpace Holdings, Inc. (NASDAQ:MEDP) Just Reported, And Analysts Assigned A US$491 Price Target","sentiment":"neutral"},{"date":"2026-02-10","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPVGE3UWU4VlBXQ1B5TEdicHZOX1l5MWNVdThwNzVPYXVuM1o0NG5aYVZ1ZGxQcmJ2Smk2cGZoUkx6ak9abmcta0hDUGZ1eXBETnpTVVFVSG1QY2ZIYXRmNWpsZ3FFM3c3RVlpWlZBUmFYWDNkS2k2WkQ2QlNRS1ViRmlVcm13VnhsWG85NEo4SVc3THhjd1FPZG9n?oc=5","date":"2026-01-08","type":"pipeline","source":"Finviz","summary":"Here's Why You Should Retain Cencora Stock in Your Portfolio Now - Finviz","headline":"Here's Why You Should Retain Cencora Stock in Your Portfolio Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNMklNQzMxaWlwcWdEQTZhblRLR19mQ0V6a3lmTVlqcEE5b0VzMk1VeGozd1poaVZhN3RRb1lNODQ2MnhRSXpVQ0dxeUdzako5NFV3aGlyM3drQ2tHczRGSGJEX014bE9ONkJtZlRidVV1SzBUeHFJMHFJTlFfOGJOZFRYRnZlTDJieGc?oc=5","date":"2025-08-12","type":"pipeline","source":"Nasdaq","summary":"Reasons to Add Veeva Systems Stock to Your Portfolio for Now - Nasdaq","headline":"Reasons to Add Veeva Systems Stock to Your Portfolio for Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5VMXA1NzJOM0x4eTdQVHk4RXhlaThrY1ZCMnZnZ3Q1djE5UFEwN05taWFydnNsSG9CcVhlZWxtNS1HekgtTlhXbnhGOWdudGdLelVjS19Da1dEcXl0UkZmTjMtZnJjdXh5NEpsNkJ3VThzc29YTjJBZWVHbWE?oc=5","date":"2025-07-22","type":"pipeline","source":"Mugglehead Magazine","summary":"Medpace Holdings stock just popped by 50%, but why? - Mugglehead Magazine","headline":"Medpace Holdings stock just popped by 50%, but why?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNOG5OMHlRNUc5TnlfZXVPUHQyUDc3S0ZNbWY1VW8ydzJuMTRWZDVFcXNMc3oxY0MtTS1FazlWbGlJN2lrbzUtWGRiSzA0cnBSeXJ2dE5lSlpWSFpxU2pWNVpzTVFFaWpYalNQc3RXVkJsZ3dPTHBoQlR4NkpDTFJ4bG4zNA?oc=5","date":"2025-07-22","type":"pipeline","source":"Investor's Business Daily","summary":"Medtech Skyrockets 50%-Plus On 'Shockingly Strong' Report - Investor's Business Daily","headline":"Medtech Skyrockets 50%-Plus On 'Shockingly Strong' Report - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQVFZaQUhYZnRsbGR6ZkhIWXU5WnF3UHhPODhyRVBUVFJwQm1UMHhJQjlYOUdRc0VjaWE0ZkhBc3hOdWZHWjNRdWRnVHFWOWpWeXJJU05qOV93aW9MQ0M5WEg5RUFWNlcya01yV1UzNm81WkJqUm1hZ2t4d0wyajQtdEc3NEZveUZqeXpjZWZfNHk0OUVYaVh5TGlUdkJ6eDdTMVlEZnE4MUlCU0FUV1E?oc=5","date":"2025-07-22","type":"pipeline","source":"The Business Journals","summary":"Medpace stock soars 53% in trading Tuesday; here’s why - The Business Journals","headline":"Medpace stock soars 53% in trading Tuesday; here’s why","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOaUltcUpGelhkSVhVMGhSOTZrcjhId1BCMjVCNk9CQmNTOTJ2b3V0ZFdacTM3YzJfRkduVURlUkhkSmJfcXNzZnVHRHNqY0ZZVG9qWWhDRnRwZUVzMlBQdXNMYlFPWnhHN2RuMGEwYWptdTdkbUVreExQRmJPVUxIZ1p0a1I5RXJxMDh6bW5Wdmt6MXdkXzh1YldPSDNGMUluakFuUXc4S3NIS2trdGhGM29wcHlGbkpTMGxQakxXck42bXhv?oc=5","date":"2025-07-22","type":"earnings","source":"Benzinga","summary":"Top 2 Health Care Stocks You May Want To Dump This Quarter - Benzinga","headline":"Top 2 Health Care Stocks You May Want To Dump This Quarter","sentiment":"neutral"}],"patents":[{"drugName":"Lynparza","drugSlug":"olaparib","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["IQVIA","PAREXEL","Labcorp"],"therapeuticFocus":["Oncology","Cardiovascular","Infectious Diseases"],"financials":{"source":"sec_edgar+yahoo","revenue":2530234000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":2530234000,"period":"2025-12-31"},{"value":2109054000,"period":"2024-12-31"},{"value":1885842000,"period":"2023-12-31"},{"value":1459996000,"period":"2022-12-31"},{"value":1142377000,"period":"2021-12-31"},{"value":925925000,"period":"2020-12-31"}],"grossProfit":760618000,"grossProfitHistory":[{"period":"2025-12-31","value":760618000},{"period":"2024-12-31","value":656305000},{"period":"2023-12-31","value":524505000},{"period":"2022-12-31","value":432438000}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":197559000,"operatingIncome":534935000,"operatingIncomeHistory":[{"period":"2025-12-31","value":534935000},{"period":"2024-12-31","value":446870000},{"period":"2023-12-31","value":336825000},{"period":"2022-12-31","value":278697000}],"netIncome":451123000,"netIncomeHistory":[{"period":"2025-12-31","value":451123000},{"period":"2024-12-31","value":404386000},{"period":"2023-12-31","value":282810000},{"period":"2022-12-31","value":245368000}],"eps":15.28,"epsHistory":[{"period":"2025-12-31","value":15.28},{"period":"2024-12-31","value":12.63},{"period":"2023-12-31","value":8.88},{"period":"2022-12-31","value":7.28}],"cash":497049000,"cashHistory":[{"period":"2025-12-31","value":497049000},{"period":"2024-12-31","value":669436000},{"period":"2023-12-31","value":245449000},{"period":"2022-12-31","value":28265000}],"totalAssets":1975472000,"totalLiabilities":1516401000,"totalDebt":113643000,"equity":459071000,"operatingCashflow":713223000,"operatingCashflowHistory":[{"period":"2025-12-31","value":713223000},{"period":"2024-12-31","value":608815000},{"period":"2023-12-31","value":433374000},{"period":"2022-12-31","value":388050000}],"capex":-31356000,"capexHistory":[{"period":"2025-12-31","value":-31356000},{"period":"2024-12-31","value":-36548000},{"period":"2023-12-31","value":-36648000},{"period":"2022-12-31","value":-36879000}],"freeCashflow":681867000,"dividendsPaid":null,"buybacks":-917389000,"employees":6300,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":47917000,"ebit":141503000,"ebitda":148409000,"period":"2026-03-31","revenue":706604000,"epsBasic":4.35,"netIncome":123870000,"rdExpense":null,"epsDiluted":4.28,"grossProfit":196326000,"operatingIncome":141503000},{"sga":44916000,"ebit":153269000,"ebitda":160400000,"period":"2025-12-31","revenue":708450000,"epsBasic":4.78,"netIncome":135133000,"rdExpense":null,"epsDiluted":4.67,"grossProfit":205316000,"operatingIncome":153269000},{"sga":48082000,"ebit":141808000,"ebitda":148857000,"period":"2025-09-30","revenue":659903000,"epsBasic":3.95,"netIncome":111135000,"rdExpense":null,"epsDiluted":3.86,"grossProfit":196939000,"operatingIncome":141808000},{"sga":46664000,"ebit":126335000,"ebitda":133349000,"period":"2025-06-30","revenue":603311000,"epsBasic":3.16,"netIncome":90260000,"rdExpense":null,"epsDiluted":3.1,"grossProfit":180013000,"operatingIncome":126335000},{"sga":57897000,"ebit":113523000,"ebitda":120453000,"period":"2025-03-31","revenue":558570000,"epsBasic":3.77,"netIncome":114595000,"rdExpense":null,"epsDiluted":3.67,"grossProfit":178350000,"operatingIncome":113523000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":422.18,"previousClose":423.76,"fiftyTwoWeekHigh":628.92,"fiftyTwoWeekLow":284.48,"fiftyTwoWeekRange":"284.48 - 628.916","fiftyDayAverage":463.02,"twoHundredDayAverage":513.36,"beta":1.19,"enterpriseValue":11595867136,"forwardPE":22.7,"priceToBook":20.15,"priceToSales":4.5,"enterpriseToRevenue":4.33,"enterpriseToEbitda":19.62,"pegRatio":2.61,"ebitda":591014976,"ebitdaMargin":22.1,"freeCashflow":490738880,"operatingCashflow":739174976,"totalDebt":146094000,"debtToEquity":24.4,"currentRatio":0.85,"returnOnAssets":17.5,"returnOnEquity":77.3,"analystRating":"","recommendationKey":"none","numberOfAnalysts":12,"targetMeanPrice":442.83,"targetHighPrice":495,"targetLowPrice":329,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":19.4,"institutionHeldPercent":87.8,"sharesOutstanding":28559689,"floatShares":22996547,"sharesShort":1550758,"shortRatio":3.32,"shortPercentOfFloat":5.4,"epsTrailing":15.89,"epsForward":18.56,"revenuePerShare":94.44,"bookValue":20.95,"officers":[{"age":69,"name":"Dr. August James Troendle M.D.","title":"Chairman & CEO"},{"age":51,"name":"Mr. Jesse J. Geiger BBA, CPA","title":"President"},{"age":50,"name":"Mr. Kevin M. Brady","title":"CFO & Treasurer"},{"age":62,"name":"Ms. Susan E. Burwig BSN, MA","title":"Executive Vice President of Operations"},{"age":56,"name":"Mr. Stephen P. Ewald J.D.","title":"Chief Compliance Officer, General Counsel & Corporate Secretary"},{"age":null,"name":"Mr. Brandon  Ebken","title":"Chief Information Officer"},{"age":null,"name":"Ms. Lauren  Morris","title":"Associate Director of Investors Relations"},{"age":null,"name":"Mr. Todd  Meyers","title":"Vice President of Business Development & Marketing"}],"industry":"Diagnostics & Research","irWebsite":"","website":"https://www.medpace.com","phone":"513 579 9911"}}